Galantamine prevents apoptosis induced by β-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors
- 1 January 2004
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 46 (1) , 103-114
- https://doi.org/10.1016/s0028-3908(03)00317-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Galantamine Provides Sustained Benefits in Patients with ‘Advanced Moderate’ Alzheimer’s Disease for at Least 12 MonthsDementia and Geriatric Cognitive Disorders, 2003
- Relationship between the increased cell surface α7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonistsJournal of Neuroscience Research, 2001
- Galantamine is an allosterically potentiating ligand of the human α4/β2 nAChRActa Neurologica Scandinavica, 2000
- Amyloid Peptide Aβ1‐42 Binds Selectively and with Picomolar Affinity to α7 Nicotinic Acetylcholine ReceptorsJournal of Neurochemistry, 2000
- Nicotinic α7 receptors protect against glutamate neurotoxicity and neuronal ischemic damagePublished by Elsevier ,1998
- Nicotinic receptor stimulation protects neurons against β‐amyloid toxicityAnnals of Neurology, 1997
- Minireview: Nicotinic Acetylcholine Receptors on Hippocampal Neurons: Distribution on the Neuronal Surface and Modulation of Receptor ActivityJournal of Receptors and Signal Transduction, 1997
- Physostigmine, galanthamine and codeine act as ‘noncompetitive nicotinic receptor agonists’ on clonal rat pheochromocytoma cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- The α-Helical to β-Strand Transition in the Amino-terminal Fragment of the Amyloid β-Peptide Modulates Amyloid FormationJournal of Biological Chemistry, 1995
- Nicotinic acetylcholine receptors in human neuroblastoma (SH-SY5Y) cellsNeuroscience Letters, 1992